
Sign up to save your podcasts
Or


Dr. Greg Cooper talks with Dr. Eric Reiman about emerging antibody therapies for preclinical Alzheimer disease and the clinical, regulatory, and equity considerations shaping prevention trials and future care.
Read the related article in The Lancet Neurology.
Disclosures can be found at Neurology.org.
By American Academy of Neurology4.7
285285 ratings
Dr. Greg Cooper talks with Dr. Eric Reiman about emerging antibody therapies for preclinical Alzheimer disease and the clinical, regulatory, and equity considerations shaping prevention trials and future care.
Read the related article in The Lancet Neurology.
Disclosures can be found at Neurology.org.

321 Listeners

504 Listeners

53 Listeners

3,374 Listeners

16 Listeners

1,150 Listeners

24 Listeners

194 Listeners

518 Listeners

134 Listeners

367 Listeners

189 Listeners

375 Listeners

325 Listeners

80 Listeners